Leading Life Science Innovation

Discover the future of omics with MGI's Next-Generation Sequencing: ultra-high throughput, scalability, and speed. Enhance your research with precision sequencing, advanced automation, and integrated bioinformatics, expanding the possibilities in genomics.

Products Catalogue

Applications

T1+:
Your discoveries.
In just 24 Hours

Our latest mid-throughput sequencer with Q40 accuracy that delivers 25Gb-1.2 Tb in 24h

Learn more

Explore our recent product promotions

DNBSEQ-G99

T1+:
Your discoveries.
In just 24 Hours

Our latest mid-throughput sequencer with Q40 accuracy that delivers 25Gb-1.2 Tb in 24h

Learn more

T1+:
Your discoveries.
In just 24 Hours

Our latest mid-throughput sequencer with Q40 accuracy that delivers 25Gb-1.2 Tb in 24h

Learn more

T1+:
Your discoveries.
In just 24 Hours

Our latest mid-throughput sequencer with Q40 accuracy that delivers 25Gb-1.2 Tb in 24h

Learn more

Leading with innovation to all Sequencing Industry Explorers

View all

Sequencing platforms

Maximize your sequencing projects with DNBSEQ™, delivering superior accuracy and efficiency for all genomic research.

Explore Products

Laboratory automation

Our scalable lab automation systems ensure adaptability, supporting applications from diagnostics to genomics.

Explore Products

Bioinformatics software

Advanced tools and sequencing technologies drive insights into genetics, empowering multiomics breakthroughs.

Explore Products

Novel Products

Unlock precision with DNBSEQ™ chemistry, NGS, Stereo-Seq, and Single-cell platforms for seamless integration in genetic studies.

Explore Products

Operating in 100+ countries with 2,900+ users, MGI's technology supports 781+ valid patent applications and over 60 petabytes of data generation with T series sequencers.

+2860

Employees Worldwide, including 33.4% in R&D, with 9 R&D centers, 7 production centers, and 10+ CEC labs.

+7500

Papers published in top scientific journals, including 900+ in CNS, Lancet, and other core journals based on the DNBSEQ platform.

Upcoming & recent

events.

See our products in action, stay up to date on our innovations, and meet our experts in person.

All Events

September 12, 2026

MGI Tech at ECP 2026: Advancing Pathology with Genomics and Proteomics

Discover MGI’s latest genomic and proteomic solutions at ECP 2026, designed to empower pathologists and researchers with new approaches to tissue and disease analysis and accelerate the transition toward more comprehensive, data-driven pathology.

Stockholm, Sweden

All Events

September 28, 2026

From data to discovery: MGI showcases spatial biology use cases at ESSB 2026

Discover how spatial and single-cell technologies can turn complex tissue biology into actionable biological insight. Meet MGI at ESSB 2026 and explore our latest Stereo-seq use cases and scientific presentations.

Barcelona, Spain

All Events

June 29, 2026

Exploring the Future of Spatial Transcriptomics at STOC 2026

oin us in Milan at the STOC General Meeting together with the STOmics team. Discover the latest innovations in spatial transcriptomics, explore emerging applications in spatial biology, and connect with our experts to discuss how cutting-edge technologies can advance your research.

Milan, Ilaty

All Events

Upcoming events.

See our products in action, stay up to date on our innovations, and meet our experts in person.

All Events

September 12, 2026

MGI Tech at ECP 2026: Advancing Pathology with Genomics and Proteomics

Stockholm, Sweden

All Events

September 28, 2026

From data to discovery: MGI showcases spatial biology use cases at ESSB 2026

Barcelona, Spain

All Events

June 29, 2026

Exploring the Future of Spatial Transcriptomics at STOC 2026

Milan, Ilaty

All Events

Upcoming events.

See our products in action, stay up to date on our innovations, and meet our experts in person.

All Events

September 12, 2026

MGI Tech at ECP 2026: Advancing Pathology with Genomics and Proteomics

Stockholm, Sweden

All Events

September 28, 2026

From data to discovery: MGI showcases spatial biology use cases at ESSB 2026

Barcelona, Spain

All Events

June 29, 2026

Exploring the Future of Spatial Transcriptomics at STOC 2026

Milan, Ilaty

All Events

In the science journal

View all

Detecting actionable fusions in solid tumors

How RNA Sequencing Is Improving Detection of Actionable Gene Fusions in Precision Oncology

Precision Oncology

Jul 3, 2026

Discover how RNA sequencing is transforming precision oncology by improving the detection of actionable gene fusions that DNA sequencing alone may miss. Learn how integrating RNA-seq into routine clinical diagnostics enables more accurate molecular profiling, expands access to targeted therapies, and supports better patient outcomes.

Metagenomics

Discover MGI's metagenomics NGS solutions for in-depth microbial analysis, from sample processing to detailed reports, uncovering hidden pathogens with cutting-edge sequencing technologies.

HIV-1 NGS solution

MGI's NGS solution enables efficient HIV-1 genotyping and drug resistance monitoring with advanced sequencing techniques for precise results.

Tuberculosis Drug Resistance Profiling

Experience rapid MTB identification, drug resistance, and traceability through sequencing with MGI's advanced tuberculosis detection and analysis solutions.

Explore Applications

Metagenomics

Discover MGI's metagenomics NGS solutions for in-depth microbial analysis, from sample processing to detailed reports, uncovering hidden pathogens with cutting-edge sequencing technologies.

HIV-1 NGS solution

MGI's NGS solution enables efficient HIV-1 genotyping and drug resistance monitoring with advanced sequencing techniques for precise results.

Tuberculosis Drug Resistance Profiling

Experience rapid MTB identification, drug resistance, and traceability through sequencing with MGI's advanced tuberculosis detection and analysis solutions.

Explore Applications

Metagenomics

Discover MGI's metagenomics NGS solutions for in-depth microbial analysis, from sample processing to detailed reports, uncovering hidden pathogens with cutting-edge sequencing technologies.

HIV-1 NGS solution

MGI's NGS solution enables efficient HIV-1 genotyping and drug resistance monitoring with advanced sequencing techniques for precise results.

Tuberculosis Drug Resistance Profiling

Experience rapid MTB identification, drug resistance, and traceability through sequencing with MGI's advanced tuberculosis detection and analysis solutions.

Explore Applications

Metagenomics

Discover MGI's metagenomics NGS solutions for in-depth microbial analysis, from sample processing to detailed reports, uncovering hidden pathogens with cutting-edge sequencing technologies.

HIV-1 NGS solution

MGI's NGS solution enables efficient HIV-1 genotyping and drug resistance monitoring with advanced sequencing techniques for precise results.

Tuberculosis Drug Resistance Profiling

Experience rapid MTB identification, drug resistance, and traceability through sequencing with MGI's advanced tuberculosis detection and analysis solutions.

Certification

ISO 13485

Medical Device Quality Management System

ISO 14001

Environmental Management System

ISO 27001

Information Security Management System

Certification

ISO 13485

Medical Device Quality Management System

ISO 14001

Environmental Management System

ISO 27001

Information Security Management System

Certification

ISO 13485

Medical Device Quality Management System

ISO 14001

Environmental Management System

ISO 27001

Information Security Management System

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Resources

Products

Bioinformatic Products

Novel Products

About MGI

Who we are